Total Payments
$18,479
2024 Payments
$1,901
Companies
26
Transactions
234
Medicare Patients
2,340
Medicare Billing
$343,356
Payment Breakdown by Category
Food & Beverage$18,451 (99.8%)
Education$28.46 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,451 | 230 | 99.8% |
| Education | $28.46 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $4,068 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,939 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,697 | 27 | $0 (2024) |
| Amgen Inc. | $2,062 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,095 | 13 | $0 (2024) |
| Lilly USA, LLC | $1,095 | 15 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,007 | 10 | $0 (2020) |
| ABBVIE INC. | $774.53 | 7 | $0 (2024) |
| Esperion Therapeutics, Inc. | $681.04 | 6 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $374.40 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,901 | 21 | Janssen Pharmaceuticals, Inc ($391.73) |
| 2023 | $1,201 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($364.81) |
| 2022 | $1,873 | 21 | Novo Nordisk Inc ($559.44) |
| 2021 | $2,584 | 23 | Novo Nordisk Inc ($807.39) |
| 2020 | $1,686 | 16 | Novo Nordisk Inc ($462.43) |
| 2019 | $3,154 | 29 | Amgen Inc. ($910.89) |
| 2018 | $2,158 | 23 | Novo Nordisk Inc ($686.08) |
| 2017 | $3,922 | 88 | Novo Nordisk Inc ($960.04) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $108.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $135.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $132.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: DIABETES | ||||||
| 05/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $109.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: DIABETES | ||||||
| 04/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $108.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $97.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Bone Health | ||||||
| 02/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 02/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diabetes Care | ||||||
| 11/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $99.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: DIABETES | ||||||
| 10/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $115.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 586 | 2,674 | $209,128 | $105,205 |
| 2022 | 12 | 561 | 2,301 | $182,858 | $94,518 |
| 2021 | 14 | 597 | 2,070 | $157,891 | $82,861 |
| 2020 | 13 | 596 | 758 | $125,818 | $60,772 |
Total Patients
2,340
Total Services
7,803
Medicare Billing
$343,356
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 438 | $93,300 | $35,416 | 38.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,800 | $56,640 | $32,556 | 57.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 121 | 121 | $23,404 | $15,173 | 64.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $7,275 | $5,912 | 81.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 69 | 73 | $6,774 | $5,234 | 77.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 20 | 20 | $5,716 | $3,213 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 44 | $6,412 | $2,521 | 39.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 75 | 78 | $2,879 | $2,297 | 79.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,930 | $1,771 | 60.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $728.00 | $589.00 | 80.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 48 | $3,070 | $523.68 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 377 | $78,198 | $30,694 | 39.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 16 | 1,500 | $45,780 | $25,414 | 55.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $20,078 | $13,787 | 68.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 31 | 31 | $10,088 | $8,642 | 85.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 62 | 63 | $5,661 | $4,308 | 76.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 19 | $8,466 | $3,940 | 46.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 19 | 19 | $5,267 | $3,145 | 59.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 69 | 70 | $2,516 | $1,983 | 78.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $1,978 | $964.76 | 48.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 33 | 33 | $1,178 | $937.05 | 79.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 48 | $2,978 | $517.00 | 17.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 17 | 20 | $670.00 | $185.43 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 286 | $57,760 | $23,171 | 40.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 13 | 1,320 | $39,060 | $21,584 | 55.3% |
About Dr. Tiffany Chit, MD
Dr. Tiffany Chit, MD is a Family Medicine healthcare provider based in Bethlehem, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1952625972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tiffany Chit, MD has received a total of $18,479 in payments from pharmaceutical and medical device companies, with $1,901 received in 2024. These payments were reported across 234 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($18,451).
As a Medicare-enrolled provider, Chit has provided services to 2,340 Medicare beneficiaries, totaling 7,803 services with total Medicare billing of $343,356. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bethlehem, PA
- Active Since 03/19/2010
- Last Updated 09/05/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952625972
Products in Payments
- JARDIANCE (Drug) $2,452
- FARXIGA (Drug) $1,667
- Ozempic (Drug) $1,435
- XARELTO (Drug) $869.60
- EVENITY (Biological) $758.40
- NEXLIZET (Drug) $681.04
- TRULICITY (Drug) $596.89
- Tresiba (Drug) $540.54
- Saxenda (Drug) $510.74
- Prolia (Biological) $491.75
- Victoza (Drug) $472.54
- Repatha (Biological) $465.95
- SOLIQUA (Drug) $452.79
- MOUNJARO (Drug) $371.01
- RYBELSUS (Drug) $346.47
- BREZTRI (Drug) $284.39
- BEVESPI AEROSPHERE (Drug) $258.44
- AIRSUPRA (Drug) $249.74
- SYNTHROID (Drug) $249.34
- FASENRA (Drug) $229.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bethlehem
Emma Fitzgibbon, Crnp, Fnp-C, CRNP, FNP-C
Family Medicine — Payments: $49,884
Family Medicine $49,884
Dr. Brian Kuronya, Do, DO
Family Medicine — Payments: $27,011
Family Medicine $27,011
Dr. Raymond Roth, D.o, D.O
Family Medicine — Payments: $16,378
Family Medicine $16,378
George Miles, D.o, D.O
Family Medicine — Payments: $10,272
Family Medicine $10,272
Dr. Michael Sopt, M.d, M.D
Family Medicine — Payments: $9,013
Family Medicine $9,013
Dr. Michael Carnathan, Md, MD
Family Medicine — Payments: $8,910
Family Medicine $8,910